Reproducibility of Her2/neu scoring in gastric cancer and assessment of the 10% cut-off rule

The application of Trastuzumab on gastric cancer patients is based on Her2/neu immunostaining. The testing method relies on visual estimation of both membranous staining intensity, and positive tumor ratio with respect to a 10% cutoff. We evaluated the effect of inter- and intraobserver variations o...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrens, Hans-Michael, Warneke, Viktoria S, Böger, Christine, Garbrecht, Nele, Jüttner, Eva, Klapper, Wolfram, Mathiak, Micaela, Oschlies, Ilske, Rudolph, Ursula, Stuhlmann-Laeisz, Christiane, Trick, David, Röcken, Christoph, Hufnagl, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329007/
https://www.ncbi.nlm.nih.gov/pubmed/25515030
http://dx.doi.org/10.1002/cam4.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329007/
https://www.ncbi.nlm.nih.gov/pubmed/25515030
http://dx.doi.org/10.1002/cam4.365

Ejemplares similares